We are live on ! Find out more
CLRBW

Cellectar Biosciences, Inc.
CLRBW

Delisted

CLRBW was delisted on the 20th of August, 2019.

Back to rankings

4 hedge funds and large institutions have $95K invested in Cellectar Biosciences, Inc. in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 2 → 4 (+2)

53% less capital invested

Capital invested by funds: $201K → $95K (-$106K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$72
2
UBS Group
UBS Group
Switzerland
+$9

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$6.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$85K -$6.06K -26,899 -12%
CAM
2
Cormorant Asset Management
Massachusetts
$10K – – –
UBS Group
3
UBS Group
Switzerland
– +$9 +40 New
Northwestern Mutual Wealth Management
4
Northwestern Mutual Wealth Management
Wisconsin
– +$72 +320 New

CLRBW Hedge Fund Activity: Q4 2016 in Review

4 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. (CLRBW) for Q4 2016, worth a combined $95K — down 53% from $201K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CLRBW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Northwestern Mutual Wealth Management, opening a new position worth an estimated $72. The largest seller was Sabby Management, cutting an estimated $6.06K.

  • 4 institutional investors held Cellectar Biosciences, Inc. (CLRBW) as of Q4 2016, up from 2 in Q3 2016.
  • Funds reported $95K of Cellectar Biosciences, Inc. stock for Q4 2016, down 53% quarter-over-quarter.
  • 2 funds opened new Cellectar Biosciences, Inc. positions in Q4 2016 and 0 closed out, a net change of +2 holders.
  • The largest Cellectar Biosciences, Inc. buyer in Q4 2016 was Northwestern Mutual Wealth Management, an estimated $72 added.
  • The largest Cellectar Biosciences, Inc. seller in Q4 2016 was Sabby Management, an estimated $6.06K sold.

Based on aggregated 13F filings for Q4 2016.